Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$23.04 +0.11 (+0.48%)
As of: Sep 9, 2026 · 3:59 PM EDT

Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026)

Analysis

Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 14.41%
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -10.40%
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -47.39%
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -30.54%
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 49.35%
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 43.55%
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn -2.33%
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 16.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.33%
Mar 31, 2026 7.44%
Dec 31, 2025 40.24%
Sep 30, 2025 47.39%
Jun 30, 2025 127.09%
Mar 31, 2025 -17.90%
Dec 31, 2024 -20.90%
Sep 30, 2024 128.49%
Jun 30, 2024 33.65%
Mar 31, 2024 45.14%
Dec 31, 2023 24.00%
Sep 30, 2023 157.36%
Jun 30, 2023 33.68%
Mar 31, 2023 88.83%
Dec 31, 2022 73.61%
Sep 30, 2022 39.48%
Jun 30, 2022 -27.27%
Mar 31, 2022 63.87%
Dec 31, 2021 703.30%
Sep 30, 2021 -51.51%